Management of hypertension in older persons

American Family Physician

Volumn 71, Issue 3, 2005, Pages 469-476

  Dickerson, Lori M ^a,b,c   Gibson, Maria V ^a,b,d,e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

^d SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BISOPROLOL FUMARATE; CALAN SR; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CANDESARTAN HEXETIL; CHLORTALIDONE; CLONIDINE; CYCLOSPORIN; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL MALEATE; FELODIPINE; GUANFACINE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; IRBESARTAN; LISINOPRIL; LOSARTAN; LOSARTAN POTASSIUM; METHYLDOPA; METOPROLOL; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; MINOXIDIL; NADOLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; PROPRANOLOL; RAMIPRIL; RESERPINE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL; UNINDEXED DRUG; VALSARTAN; VERAPAMIL;

ACUTE KIDNEY FAILURE; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; ATRIOVENTRICULAR BLOCK; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; COUGHING; DEHYDRATION; DEPRESSION; DIET THERAPY; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; ELECTROLYTE DISTURBANCE; FOOD DRUG INTERACTION; GINGIVA HYPERPLASIA; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; LOW DRUG DOSE; META ANALYSIS; METABOLIC DISORDER; ORTHOSTATIC HYPERTENSION; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PHYSICAL ACTIVITY; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SODIUM RESTRICTION; STROKE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; WEIGHT REDUCTION; XEROSTOMIA;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION; LIFE STYLE; MIDDLE AGED; PRACTICE GUIDELINES; SYSTOLE;

EID: 13244249790     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Projected population of the United States, by age and sex: 2000 to 2050. Accessed online September 29, 2004, at: http://www.census.gov/ipc/www/ usinterimproj/natprojtab02a.pdf.
2. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
3. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002;287:1003-10.
4. Mulrow C, Lau J, Cornell J, Brand M. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2004;(3):CD000028.
5. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869-74.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
7. Francos GC, Schairer HL Jr. Hypertension. Contemporary challenges in geriatric care. Geriatrics 2003;58:44-9.
8. Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000;160:1085-9.
9. Lakatta EG. Cardiovascular aging in health. Clin Geriatr Med 2000;16:419-44.
10. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999;282:539-46.
11. Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999;159:2004-9.
12. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials [published erratum appears in Lancet 2001;357:724]. Lancet 2000;355:865-72.
13. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials [published erratum appears in Lancet 2001;357:724]. Lancet 2000;355:865-72.
14. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [published erratum appears in JAMA 2003;289:178]. JAMA 2002;288:2981-97.
15. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [published erratum appears in JAMA 2003;289:178]. JAMA 2002;288:2981-97.
16. Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanke J, Schersten B, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999;354:1751-6.
17. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
18. Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. JAMA 2003;290:2805-16.
19. Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348:583-92.
20. Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. Lancet 1999;353:793-6.
21. Malacco E, Mancia G, Rappelli A, Menotti A, Zuccaro MS, Coppini A. Treatment of isolated systolic hypertension: the SHELL study results. Blood Press 2003;12:160-7.
22. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of non-pharmacologic interventions in the elderly (TONE) [published erratum appears in JAMA 1998;279:1954]. JAMA 1998;279:839-46.
23. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of non-pharmacologic interventions in the elderly (TONE) [published erratum appears in JAMA 1998;279:1954]. JAMA 1998;279:839-46.
24. Sacks FM, Svetkey LP, Vollmer WM, Appel JL, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001;344:3-10.
25. E-facts. The next dimension in drug information. Facts and Comparisons. Wolters Kluwer Health, Inc. Accessed online September 29, 2004, at: http://www.efactsonline.com/.
26. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure [published erratum appears in Arch Intern Med 1998;158:573]. Arch Intern Med 1997;157:2413-46.
27. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure [published erratum appears in Arch Intern Med 1998;158:573]. Arch Intern Med 1997;157:2413-46.
28. Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use in cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000;35:1025-30.
29. Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Arch Intern Med 1999;159:551-8.
30. Gavras I, Gavras H. Are patients who develop angioedema with ACE inhibition at risk of the same problem with AT1 receptor blockers? Arch Intern Med 2003;163:240-1.
31. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000;160:685-93.
32. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-14.
33. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289:2534-44.
34. Slavachevsky I, Rachmani R, Levi Z, Brosh D, Lidar M, Ravid M. Effect of enalapril and nifedipine on orthostatic hypotension in older hypertensive patients. J Am Geriatr Soc 2000;48:807-10.